Literature DB >> 25533964

Paradoxical normoxia-dependent selective actions of inorganic nitrite in human muscular conduit arteries and related selective actions on central blood pressures.

Sami A Omar1, Henry Fok1, Katharina D Tilgner1, Ashok Nair1, Joanne Hunt1, Benyu Jiang1, Paul Taylor1, Phil Chowienczyk1, Andrew J Webb2.   

Abstract

BACKGROUND: Inorganic nitrite dilates small resistance arterioles via hypoxia-facilitated reduction to vasodilating nitric oxide. The effects of nitrite in human conduit arteries have not been investigated. In contrast to nitrite, organic nitrates are established selective dilators of conduit arteries. METHODS AND
RESULTS: We examined the effects of local and systemic administration of sodium nitrite on the radial artery (a muscular conduit artery), forearm resistance vessels (forearm blood flow), and systemic hemodynamics in healthy male volunteers (n=43). Intrabrachial sodium nitrite (8.7 μmol/min) increased radial artery diameter by a median of 28.0% (25th and 75th percentiles, 25.7% and 40.1%; P<0.001). Nitrite (0.087-87 μmol/min) displayed conduit artery selectivity similar to that of glyceryl trinitrate (0.013-4.4 nmol/min) over resistance arterioles. Nitrite dose-dependently increased local cGMP production at the dose of 2.6 μmol/min by 1.1 pmol·min(-1)·100 mL(-1) tissue (95% confidence interval, 0.5-1.8). Nitrite-induced radial artery dilation was enhanced by administration of acetazolamide (oral or intra-arterial) and oral raloxifene (P=0.0248, P<0.0001, and P=0.0006, respectively) but was inhibited under hypoxia (P<0.0001) and hyperoxia (P=0.0006) compared with normoxia. Systemic intravenous administration of sodium nitrite (8.7 μmol/min) dilated the radial artery by 10.7% (95% confidence interval, 6.8-14.7) and reduced central systolic blood pressure by 11.6 mm Hg (95% confidence interval, 2.4-20.7), augmentation index, and pulse wave velocity without changing peripheral blood pressure.
CONCLUSIONS: Nitrite selectively dilates conduit arteries at supraphysiological and near-physiological concentrations via a normoxia-dependent mechanism that is associated with cGMP production and is enhanced by acetazolamide and raloxifene. The selective central blood pressure-lowering effects of nitrite have therapeutic potential to reduce cardiovascular events.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  arteries; blood pressure; nitrites; nitroglycerin; vasodilation

Mesh:

Substances:

Year:  2014        PMID: 25533964     DOI: 10.1161/CIRCULATIONAHA.114.009554

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  30 in total

Review 1.  Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.

Authors:  Julio A Chirinos
Journal:  J Cardiovasc Transl Res       Date:  2017-04-11       Impact factor: 4.132

Review 2.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

Authors:  Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

Review 3.  Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?

Authors:  Henry Fok; J Kennedy Cruickshank
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 4.  Pulsatile arterial haemodynamics in heart failure.

Authors:  Thomas Weber; Julio A Chirinos
Journal:  Eur Heart J       Date:  2018-11-14       Impact factor: 29.983

5.  Reply to 'Comment on 'Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomised controlled VaSera trial' by Faconti et al.'

Authors:  Luca Faconti; J Kennedy Cruickshank; Andrew James Webb
Journal:  Br J Clin Pharmacol       Date:  2019-03-04       Impact factor: 4.335

6.  Ventricular-Arterial Coupling in Chronic Heart Failure.

Authors:  Julio A Chirinos; Nancy Sweitzer
Journal:  Card Fail Rev       Date:  2017-04

Review 7.  INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design.

Authors:  Yogesh N V Reddy; Gregory D Lewis; Sanjiv J Shah; Martin LeWinter; Marc Semigran; Victor G Davila-Roman; Kevin Anstrom; Adrian Hernandez; Eugene Braunwald; Margaret M Redfield; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2017-05       Impact factor: 8.790

8.  Late Systolic Myocardial Loading Is Associated With Left Atrial Dysfunction in Hypertension.

Authors:  Julio A Chirinos; Timothy S Phan; Amer A Syed; Zeba Hashmath; Harry G Oldland; Maheswara R Koppula; Ali Tariq; Khuzaima Javaid; Rachana Miller; Swapna Varakantam; Anjaneyulu Dunde; Vadde Neetha; Scott R Akers
Journal:  Circ Cardiovasc Imaging       Date:  2017-06       Impact factor: 7.792

9.  Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma.

Authors:  Anna B Catino; Rebecca A Hubbard; Julio A Chirinos; Ray Townsend; Stephen Keefe; Naomi B Haas; Igor Puzanov; James C Fang; Neeraj Agarwal; David Hyman; Amanda M Smith; Mary Gordon; Theodore Plappert; Virginia Englefield; Vivek Narayan; Steven Ewer; Chantal ElAmm; Daniel Lenihan; Bonnie Ky
Journal:  Circ Heart Fail       Date:  2018-03       Impact factor: 8.790

Review 10.  The Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection Fraction.

Authors:  Julio A Chirinos; Payman Zamani
Journal:  Curr Heart Fail Rep       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.